Noradrenaline release from rat sympathetic neurones triggered by activation of B2 bradykinin receptors

British Journal of Pharmacology

Volumn 122, Issue 3, 1997, Pages 455-462

  Boehm, Stefan ^a   Huck, Sigismund ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

B2 bradykinin receptor; GTP binding proteins; K(M) channels; Noradrenaline release; Sympathetic neurones

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA 2 ADRENERGIC RECEPTOR; BRADYKININ; BRADYKININ B1 RECEPTOR AGONIST; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; BRADYKININ DERIVATIVE; BRIMONIDINE; CADMIUM; CAFFEINE; CALCIUM ION; CHOLERA TOXIN; GUANINE NUCLEOTIDE BINDING PROTEIN; ICATIBANT; NICOTINE; NORADRENALIN; PERTUSSIS TOXIN; POTASSIUM CHANNEL; TETRODOTOXIN; TETRYLAMMONIUM; THAPSIGARGIN; TRITIUM;

ACTION POTENTIAL; ADRENERGIC TRANSMISSION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; EXTRACELLULAR CALCIUM; ISOTOPE LABELING; NERVE CELL CULTURE; NEUROTRANSMITTER RELEASE; NEWBORN; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RADIOACTIVITY; RAT; SUPERIOR CERVICAL GANGLION; SYMPATHETIC NERVE CELL;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; BRADYKININ; CADMIUM; CALCIUM; CELLS, CULTURED; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; POTASSIUM CHANNEL BLOCKERS; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B2; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, BRADYKININ; SUPERIOR CERVICAL GANGLION; TETRODOTOXIN; THAPSIGARGIN;

EID: 0030929175     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701404     Document Type: Article

References (54)

1. AKAIKE, N. & SADOSHIMA, J.-I. (1989). Caffeine affects four different ionic currents in the bull-frog sympathetic neurone. J. Physiol., 412, 221-244.
2. 2-purinoceptor activation. Naunyn-Schmiedeberg's Arch. Pharmacol., 350, 454-458.
3. 2+ channels. Neuroscience, 69, 221-231.
4. 2-autoreceptors control sympathetic transmitter release. Eur. J. Neurosci., 8, 1924-1931.
5. BOEHM, S. & HUCK, S. (1997). Receptors controlling transmitter release from sympathetic neurons in vitro. Prog. Neurobiol., 51, 225-242.
6. BOEHM, S. HUCK, S. & ILLES, P. (1995). UTP- and ATP- triggered transmitter release from rat sympathetic neurons via separate receptors. Br. J. Pharmacol., 116, 2341-2343.
7. 2-autoreceptors in chick sympathetic neurons. J. Neurochem., 66, 1019-1026.
8. BOLAND, L.M., ALLEN, A.C. & DINGLEDINE, R. (1991). Inhibition by bradykinin of voltage-activated barium current in a rat dorsal root ganglion cell line: role of protein kinase C. J. Neurosci., 11, 1140-1149.
9. 2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J. Biol. Chem., 270, 13706-13710.
10. BROWN, D.A. (1983). Slow cholinergic excitation - a mechanism for increasing neuronal excitability. Trends Neurosci., 6, 302-307.
11. BROWN, D.A. & HIGASHIDA, H. (1988). Membrane current responses of NG108-15 mouse neuroblastoma x rat glioma hybrid cells to bradykinin. J. Physiol., 397, 167-184.
12. CHULAK, C., COUTURE, R. & FOUCART, S. (1995). Modulatory effect of bradykinin on the release of noradrenaline from rat isolated atria. Br. J. Pharmacol., 115, 330-334.
13. DELEAN, A., MUNSON, P.J. & RODBARD, D. (1978). Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol., 235, E97-E102.
14. DOMINIAK, P., SIMON, M., BLÖCHL, A. & BRENNER, P. (1992). Changes in peripheral sympathetic outflow of pithed spontaneously hypertensive rats after bradykinin and desArg-Bradykinin infusions: influence of converting-enzyme inhibition. J. Cardiovasc. Pharmacol., 20, S35-S38.
15. DRAY, A. & PERKINS, M. (1993). Bradykinin and inflammatory pain. Trends Neurosci., 16, 99-104.
16. 2+ channels in rat dorsal root ganglion neurons in vitro. Neuron., 2, 1185-1193.
17. FARMER, S.G. & BURCH, R.M. (1992). Biochemical and molecular pharmacology of kinin receptors. Ann. Rev. Pharmacol. Toxicol., 32, 511-536.
18. 3 receptor. Br. J. Pharmacol., 112, 461-464.
19. 2+ pools. Am. J. Physiol., 268, C829-C837.
20. FREISSMUTH, M., BOEHM, S., BEINDL, W., NICKEL, P., IJZERMAN, A.P., HOHENEGGER, M. & NANOFF, C. (1996). Suramin analogues as subtype selective G protein inhibitors. Mol. Pharmacol., 49, 602-611.
21. GEPPETTI, P. (1993). Sensory neuropeptide release by bradykinin: mechanisms and pathophysiological implications. Regul. Peptides, 47, 1-23.
22. GRIESBACHER, T. & LEMBECK, F. (1992). Analysis of the antagonistic actions of HOE 140 and other novel bradykinin analogues on the guinea-pig ileum. Eur. J. Pharmacol., 211, 393-398.
23. GUTOWSKI, S., SMRCKA, A., NOWAK, L., WU, D., SIMON, M. & STERNWEIS, P.C. (1991). Antibodies to the αq subfamily of guanine nucleotide-binding regulatory protein α subunits attenuate activation of phosphatidylinositol 4,5-bisphosphate hydrolysis by hormones. J. Biol. Chem., 266, 20519-20524.
24. HALL, J.M. (1992). Bradykinin receptors: pharmacological propertics and biological roles. Pharmacol. Ther., 56, 131-190.
25. HALL, J.M. & GEPPETTI, P. (1995). Kinins and kinin receptors in the nervous system. Neurochem. Int., 26, 17-26.
26. HEPLER, J.R. & GILMAN, A.G. (1992). G proteins. Trends Biochem. Sci., 17, 383-387.
27. i to production of inositol 1,4,5-triphosphate, a second messenger in NG108-15 neuroblastoma-glioma hybrid cells. Proc. Natl. Acad. Sci. U.S.A., 83, 942-946.
28. HILL, C.E., POWIS, D.A. & HENDRY, I.A. (1993). Involvement of pertussis toxin-sensitive and -insensitive mechanisms in α-adrenoceptor modulation of noradrenaline release from rat sympathetic neurons in tissue culture. Br. J. Pharmacol., 110, 281-288.
29. HOCK, F.J., WIRTH, K., ALBUS, U., LINZ, W., GERHARDS, H.J., WIEMER, G., HENKE, S., BREIPOHL, G., KÖNIG, W., KNOLLE, J. & SCHÖLKENS, B.A. (1991). Hoe 140, a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol., 102, 769-773.
30. αq 11. Neuron., 14, 400-405.
31. LEVINE, J.D., TAIWO, Y.O., COLLIN, S.D. & TAM, J.K. (1986). Noradrenaline hyperalgesia is mediated through interaction with sympathetic postganglionic neurone terminals rather than activation of primary afferent nociceptors. Nature, 323, 158-160.
32. LEWIS, G.P. & REIT, E. (1965). The action of angiotensin and bradykinin on the superior cervical ganglion of the cat. J. Physiol., 179, 538-553.
33. LLONA, I., GALLEGUILLOS, X., BELMAR, J. & HUIDOBRO-TORO, J.P. (1991). Bradykinin modulates the release of noradrenaline from vas deferens nerve terminals. Life Sci., 48, 2585-2592.
34. MAAS, J., RAE, G.A., HUIDOBRO-TORO, J.P. & CALIXTO, J.B. (1995). Characterization of kinin receptors modulating neurogenic contractions of the mouse isolated vas deferens. Br. J. Pharmacol., 114, 1471-1477.
35. MARSH, S.J. & BROWN, D.A. (1991). Potassium currents contributing to action potential repolarization is dissociated cultured rat superior cervical sympathetic neurones. Neurosci. Lett., 133, 298-302.
36. 3H]noradrenaline from the human neuroblastoma SH-SY 5Y. Biochem. Pharmacol., 48, 23-30.
37. 2 bradykinin receptor. Proc. Natl. Acad. Sci. U.S.A., 88, 7724-7728.
38. MIAO, F.J.-P., JÄNIG, W. & LEVINE, J.D. (1996). Role of sympathetic postganglionic neurons in synovial plasma extravasation induced by bradykinin. J. Neurophysiol., 75, 715-724.
39. NANOFF, C., BOEHM, S., HOHENEGGER, M., SCHÜTZ, W. & FREISSMUTH, M. (1994). 2′,3′-Dialdehyde GTP as an irreversible G protein antagonist: disruption and reconstitution of G protein-mediated signal transduction in cells and cell membranes. J. Biol. Chem., 269, 31999-32007.
40. OWEN, P.J., PLEVIN, R. & BOARDER, M.R. (1989). Characterization of bradykinin-stimulated release of noradrenaline from cultured bovine adrenal chromaffin cells. J. Pharmacol. Exp. Ther., 248, 1231-1236.
41. 2+ in cultured sympathetic neurons. Neuroscience, 52, 973-986.
42. 2 receptor characterization. Trends Pharmacol. Sci., 11, 156-161.
43. 2+ stores in glioma and neuroblastoma-glioma hybrid cells. Exp. Cell Res., 202, 440-449.
44. 2-receptor antagonists. Hypertension, 17, 107-115.
45. ROBBINS, J., TROUSLARD, J., MARSH, S.J. & BROWN, S.A. (1992). Kinetic and pharmacological properties of the M-current in rodent neuroblastomaxgliome hybrid cells. J. Physiol., 451, 159-185.
46. 3H]norepinephrine release by activation of alpha-2 adrenergic receptors in cultured rat ganglion cells. Neuroscience, 52, 107-113.
47. STANSFIELD, C.E., MARSH, S.J., GIBB, A.J. & BROWN, D.A. (1993). Inhibition of M-channels in outside-out patches excised from sympathetic ganglion cells. Neuron, 10, 639-654.
48. STARKE, K. (1987). Presynaptic α-autoreceptors. Rev. Physiol. Biochem. Pharmacol., 107, 73-146.
49. STARKE, K., PESKAR, B.A., SCHUMACHER, K.A. & TAUBE, H.D. (1977). Bradykinin and postganglionic sympathetic transmission. Naunyn-Schmiedeberg's Arch. Pharmacol., 299, 23-32.
50. 2+-ATPase inhibitor, thapsigargin. Agents Actions, 29, 8-15.
51. THAYER, S.A., HIRNING, L.D. & MILLER, R.J. (1988). The role of caffeine-sensitive calcium stores in the regulation of the intracellular free calcium concentration in rat sympathetic neurons in vitro. Mol. Pharmacol., 34, 664-673.
52. TRENDELENBURG, U. (1966). Observations on the ganglion-stimulating action of angiotensin and bradykinin. J. Pharmacol. Exp. Ther., 154, 418-425.
53. VILLARROEL, A. (1996). M-current suppression in PC12 cells by bradykinin is mediated by a pertussis toxin-sensitive G-protein and modulated by intracellular calcium. Brain Res., 740, 227-233.
54. WALKER, K., PERKINS, M. & DRAY, A. (1995). Kinins and kinin receptors in the nervous system. Neurochem. Int., 26, 1-16.